Your browser doesn't support javascript.
loading
Sunitinib 2 weeks on, 1 off: strengths and weaknesses.
Iacovelli, R; Verri, E; Cossu Rocca, M; Aurilio, G; Cullurà, D; Nolé, F.
Affiliation
  • Iacovelli R; Medical Oncology Unit of Urogenital and Head & Neck Tumors, European Institute of Oncology, Milan PhD Program, Sapienza University of Rome, Rome, Italy roberto.iacovelli@ieo.it.
  • Verri E; Medical Oncology Unit of Urogenital and Head & Neck Tumors, European Institute of Oncology, Milan.
  • Cossu Rocca M; Medical Oncology Unit of Urogenital and Head & Neck Tumors, European Institute of Oncology, Milan.
  • Aurilio G; Medical Oncology Unit of Urogenital and Head & Neck Tumors, European Institute of Oncology, Milan.
  • Cullurà D; Medical Oncology Unit of Urogenital and Head & Neck Tumors, European Institute of Oncology, Milan.
  • Nolé F; Medical Oncology Unit of Urogenital and Head & Neck Tumors, European Institute of Oncology, Milan.
Ann Oncol ; 26(7): 1511-2, 2015 Jul.
Article in En | MEDLINE | ID: mdl-25846552
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Carcinoma, Renal Cell / Angiogenesis Inhibitors / Protein Kinase Inhibitors / Indoles / Kidney Neoplasms Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2015 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Carcinoma, Renal Cell / Angiogenesis Inhibitors / Protein Kinase Inhibitors / Indoles / Kidney Neoplasms Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2015 Type: Article Affiliation country: Italy